Varun Vithal Bichu

Varun Vithal Bichu

Active Director Additional Director DIN 07193830
DIN 07193830 First appointment May 2015 Primary industry Chemicals and Materials
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2015
Shareholding value β€’β€’β€’β€’ Premium profile

About Varun Vithal Bichu

Data last updated:

Varun Vithal Bichu is an Additional Director at Semit Pharmaceuticals And Chemicals Ltd (since 2015). The company operates in Chemicals and Materials.

DIN 07193830
Primary Designation Additional Director
Industry Chemicals and Materials
First Appointment 28 May 2015
Oldest Company Age 45 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director28 May 20151981Active

Board colleagues of Varun Vithal Bichu

Directorship timeline

Open interactive timeline →
Semit Pharmaceuticals And Chemicals Ltd
Premium access

Shareholding and investment profile for Varun Vithal Bichu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Varun Vithal Bichu

Varun Vithal Bichu currently holds 1 directorship: Semit Pharmaceuticals And Chemicals Ltd (Additional Director, since 28 May 2015).

Varun Vithal Bichu was first appointed on 28 May 2015 as Additional Director at Semit Pharmaceuticals And Chemicals Ltd.

The current boards of Varun Vithal Bichu's companies include Arun Vidyarthi Pathak (Semit Pharmaceuticals And Chemicals Ltd), Vivek Shashikant Naik (Semit Pharmaceuticals And Chemicals Ltd).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available